Artículo
WHO essential medicines for reproductive health
Fecha de publicación:
12/2019
Editorial:
BMJ Publishing Group
Revista:
BMJ Global Health
e-ISSN:
2059-7908
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
Since 1977, the WHO’s Model List of Essential Medicines has been a rigorous evidence-based document providing a list of essential and lifesaving medicines. Specifically, over the course of the last few decades, a large body of scientific evidence and programmatic use has accumulated for existing medicines for reproductive health and the development of new life-saving therapies. The 21st edition of the WHO Model List of Essential Medicines issued in June 2019, added heat stable carbetocin and tranexamic acid (TXA) to the core list of medicines for reproductive health and moved mifepristone and misoprostol from the complementary to the core list. All of these medicines are important for preventing the leading causes of maternal morbidity and mortality...
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(CIESP)
Articulos de CENTRO DE INVESTIGACIONES EN EPIDEMIOLOGIA Y SALUD PUBLICA
Articulos de CENTRO DE INVESTIGACIONES EN EPIDEMIOLOGIA Y SALUD PUBLICA
Citación
Gill, Roopan; Ganatra, Bela; Althabe, Fernando; WHO essential medicines for reproductive health; BMJ Publishing Group; BMJ Global Health; 4; 6; 12-2019; 1-2
Compartir
Altmétricas